GO:1902511 negative regulation of apoptotic DNA fragmentation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902511 describes any process that stops, prevents, or reduces apoptotic DNA fragmentation, the endonucleolytic cleavage of DNA during apoptosis.
• The major apoptotic nuclease DFF40/CAD is kept inactive by its chaperone and inhibitor DFF45/ICAD; release of this inhibition is a key control point for DNA fragmentation [2,4].
• Negative regulation of apoptotic DNA fragmentation is essential for preventing inappropriate DNA damage in cells that survive apoptotic stimuli, and its dysregulation contributes to cancer, autoimmune disease, and degenerative conditions [2,6].
• Key regulators include DFF45/ICAD, DFF40/CAD, CD45, BRCA1, BRCA2, and microRNA-mediated transcriptional decoys [2,4,5,6,8].
• Experimental approaches such as TUNEL, comet assay, and caspase-3 activity assays are used to quantify apoptotic DNA fragmentation and its negative regulation.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes controlling apoptotic DNA fragmentation [2,5].
Description
Apoptosis is a genetically programmed form of cell death that is essential for development, tissue homeostasis, and immune defense. A hallmark of the terminal phase of apoptosis is the cleavage of genomic DNA into internucleosomal fragments, a process carried out by specific nucleases such as DNA fragmentation factor 40 (DFF40/CAD). However, DNA fragmentation must be tightly controlled because unintended DNA breaks can cause genomic instability, autoimmunity, or inappropriate cell death [2,6]. The Gene Ontology term GO:1902511, negative regulation of apoptotic DNA fragmentation, captures the biological processes that stop, prevent, or reduce this DNA cleavage. Understanding this term is critical for researchers studying cell survival decisions, cancer chemotherapy resistance, and degenerative diseases where apoptotic DNA fragmentation is either excessive or insufficient. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models relevant to GO:1902511 [2,4,6].
negative regulation of apoptotic DNA fragmentation At A Glance
| GO ID | GO:1902511 |
|---|---|
| GO term | negative regulation of apoptotic DNA fragmentation |
| Ontology | biological_process |
| Synonym | inhibition of apoptotic DNA fragmentation; downregulation of DNA catabolic process during apoptosis; negative regulation of endonucleolytic DNA catabolic process involved in apoptosis |
| Major function | Prevents or reduces the endonucleolytic cleavage of DNA that occurs during apoptosis, thereby protecting genomic integrity and modulating cell death outcomes [2,4]. |
| Key regulators | DFF45/ICAD, DFF40/CAD, CD45, BRCA1, BRCA2, microRNAs [2,4,5,6,8]. |
| Associated diseases | Cancer, autoimmune disorders, neurodegenerative conditions [2,6,7]. |
| Research methods | TUNEL, comet assay, caspase-3 activity, CRISPR knockout/knock-in, overexpression [3,5]. |
What Is GO:1902511?
GO:1902511 (negative regulation of apoptotic DNA fragmentation) is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of apoptotic DNA fragmentation. In practice, this includes molecular mechanisms that inhibit the endonucleolytic cleavage of DNA during apoptosis, such as the sequestration of active nucleases, the inhibition of caspase-activated DNase (CAD/DFF40), or the upregulation of protective factors that block DNA degradation [2,4].
Why Is negative regulation of apoptotic DNA fragmentation Important in Cell Biology?
Negative regulation of apoptotic DNA fragmentation is important because it determines whether a cell commits to irreversible death or survives a pro-apoptotic insult. The balance between DFF40/CAD activity and its inhibitor DFF45/ICAD is a critical checkpoint; loss of this regulation can lead to uncontrolled DNA degradation, while excessive inhibition can promote tumorigenesis by allowing damaged cells to escape apoptosis [2,4]. Moreover, understanding this process informs the development of chemotherapeutic strategies that either sensitize cancer cells to apoptosis or protect normal tissues from collateral damage.
• Prevents inappropriate DNA damage in cells that survive apoptotic stimuli.
• Modulates the threshold for irreversible cell death in cancer chemotherapy.
• DFF45/ICAD mutations or dysregulation are linked to tumor progression and therapy resistance.
• CD45-mediated negative regulation of apoptosis in immature B cells is critical for immune tolerance.
• BRCA1 and BRCA2 expression is regulated by DNA-damaging agents, linking DNA repair and apoptotic DNA fragmentation.
• MicroRNAs can act as decoys of transcription factors to modulate apoptotic gene expression.
• N-acetyl-L-cysteine can regulate DNA fragmentation against methoxychlor toxicity in granulosa cells.
• Mitophagy influences apoptosis and oxidative stress during myoblast differentiation, indirectly affecting DNA fragmentation.
• Provides therapeutic targets for autoimmune and neurodegenerative diseases [2,6].
• Essential for understanding the molecular basis of cell survival decisions.
What Happens During negative regulation of apoptotic DNA fragmentation?
Inhibition of CAD/DFF40 nuclease activity
In simple terms: The main DNA-cutting enzyme is kept switched off by a partner protein.
The primary apoptotic nuclease DFF40/CAD is synthesized as an inactive complex with its chaperone and inhibitor DFF45/ICAD. The DFF-C domain of DFF45/ICAD binds to DFF40/CAD and prevents its nuclease activity, providing a structural basis for the regulation of apoptotic DNA fragmentation. Negative regulation of apoptotic DNA fragmentation occurs when this inhibitory interaction is maintained or enhanced, blocking DNA cleavage even in the presence of apoptotic signals [2,4].
Caspase-mediated cleavage of DFF45/ICAD
In simple terms: When caspases cut the inhibitor, the DNA-cutting enzyme is released.
During apoptosis, effector caspases cleave DFF45/ICAD, releasing active DFF40/CAD to enter the nucleus and fragment DNA. Negative regulation of apoptotic DNA fragmentation can occur when caspase activation is suppressed or when DFF45/ICAD cleavage is prevented, thereby keeping DFF40/CAD in its inactive state [2,4].
Transcriptional and post-transcriptional control
In simple terms: Cells can change how much of the inhibitor or nuclease is made.
MicroRNAs can act as endogenous decoys of transcription factors to modulate the expression of genes involved in apoptosis, including those controlling DNA fragmentation. Additionally, DNA-damaging agents regulate BRCA1 and BRCA2 expression, which may indirectly influence apoptotic DNA fragmentation pathways. These transcriptional and post-transcriptional mechanisms contribute to the negative regulation of apoptotic DNA fragmentation [5,8].
Signaling pathways that block DNA fragmentation
In simple terms: External signals can tell the cell not to cut its DNA.
CD45, a transmembrane phosphatase, negatively regulates apoptotic death in immature B cells, thereby preventing DNA fragmentation. Similarly, mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation, which can impact downstream DNA fragmentation. These pathways illustrate how extracellular and intracellular signals converge to negatively regulate apoptotic DNA fragmentation [1,6].
Key Genes Involved in GO:1902511 negative regulation of apoptotic DNA fragmentation
The following genes and proteins are experimentally implicated in the negative regulation of apoptotic DNA fragmentation, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DFF45/ICAD | Inhibits DFF40/CAD nuclease; chaperone | Structural basis for inhibition of apoptotic DNA fragmentation. |
| DFF40/CAD | Major apoptotic nuclease; cleaves DNA | Target of negative regulation; key effector of DNA fragmentation. |
| CD45 | Transmembrane phosphatase; negative regulator of apoptosis in B cells | Prevents apoptotic DNA fragmentation in immature B cells. |
| BRCA1 | DNA repair and transcription regulation | Expression regulated by DNA-damaging agents; links to apoptotic pathways. |
| BRCA2 | DNA repair and recombination | Expression regulated by DNA-damaging agents; links to apoptotic pathways. |
| Caspase-3 | Effector caspase; cleaves DFF45/ICAD | Activation leads to DNA fragmentation; negative regulation blocks this step. |
| Caspase-7 | Effector caspase; cleaves DFF45/ICAD | Redundant with caspase-3 in DFF45/ICAD cleavage. |
| MicroRNAs (e.g., miR- decoys) | Transcriptional decoys of transcription factors | Modulate apoptotic gene expression. |
| N-acetyl-L-cysteine (NAC) target genes | Antioxidant response | Regulates DNA fragmentation against methoxychlor toxicity. |
| Mitophagy regulators (e.g., Parkin, BNIP3) | Mitochondrial quality control | Influence apoptosis and oxidative stress during differentiation. |
| Apoptosis protease-activating factor 1 (APAF-1) | Apoptosome formation | Upstream of caspase activation and DNA fragmentation. |
| Bcl-2 family proteins | Mitochondrial outer membrane permeabilization | Regulate cytochrome c release and downstream DNA fragmentation. |
| Inhibitor of apoptosis proteins (IAPs) | Caspase inhibition | Block caspase activation and subsequent DNA fragmentation. |
| p53 | Tumor suppressor; transcription factor | Induces apoptosis and modulates DNA fragmentation. |
| NF-κB | Transcription factor; survival signaling | Can negatively regulate apoptotic DNA fragmentation. |
| Akt/PKB | Survival kinase | Phosphorylates and inhibits pro-apoptotic factors. |
| MicroRNA-21 | OncomiR; targets apoptotic genes | May negatively regulate apoptotic DNA fragmentation. |
| MicroRNA-24 | Regulates apoptosis | Potential decoy of transcription factors. |
How Is negative regulation of apoptotic DNA fragmentation Regulated?
The negative regulation of apoptotic DNA fragmentation is controlled at multiple levels. The DFF45/ICAD-DFF40/CAD interaction is the primary checkpoint; phosphorylation, caspase cleavage, and subcellular localization of these proteins modulate the process [2,4]. Upstream, survival signaling pathways such as PI3K/Akt and NF-κB can inhibit caspase activation, thereby preventing DFF45/ICAD cleavage and DNA fragmentation. CD45 phosphatase activity negatively regulates apoptosis in immature B cells, providing an example of cell-type-specific control. Additionally, microRNAs can act as decoys of transcription factors to fine-tune the expression of apoptotic genes. Mitophagy and mitochondrial quality control also influence oxidative stress and apoptosis, indirectly affecting DNA fragmentation.
negative regulation of apoptotic DNA fragmentation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DFF45/ICAD | Cancer chemoresistance | Knockout or overexpression in cancer cell lines. |
| DFF40/CAD | Cancer, autoimmune disease | Point mutation of nuclease domain; knock-in. |
| CD45 | Autoimmune disease | Knockout in B cell lines; overexpression. |
| BRCA1/BRCA2 | Breast/ovarian cancer | Knockout in breast cancer cells; point mutation. |
| Caspase-3 | Neurodegeneration | Knockout in neuronal cells; overexpression. |
Cancer
Defects in the negative regulation of apoptotic DNA fragmentation can allow cancer cells to survive despite DNA damage, contributing to chemoresistance [2,7]. For example, overexpression of DFF45/ICAD or loss of DFF40/CAD activity has been observed in some tumors, preventing DNA fragmentation and apoptosis. BRCA1 and BRCA2, which are regulated by DNA-damaging agents, are frequently mutated in breast and ovarian cancers, linking DNA repair defects to apoptotic pathways.
Autoimmune and inflammatory diseases
Impaired negative regulation of apoptotic DNA fragmentation can lead to the release of undegraded DNA, triggering autoimmune responses [2,6]. CD45-mediated negative regulation of apoptosis in immature B cells is critical for preventing autoimmunity; dysregulation of this pathway may contribute to autoimmune diseases.
Neurodegenerative disorders
Excessive apoptotic DNA fragmentation is a feature of neuronal loss in neurodegenerative diseases. Enhancing negative regulation of apoptotic DNA fragmentation could be neuroprotective, although the mechanisms remain under investigation [2,7].
Reproductive toxicity
In ovarian granulosa cells, methoxychlor toxicity induces DNA fragmentation, which can be mitigated by N-acetyl-L-cysteine, highlighting the role of negative regulation in reproductive toxicology.
From negative regulation of apoptotic DNA fragmentation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DFF45/ICAD increase apoptotic DNA fragmentation? | DFF45/ICAD knockout cell line. |
| Does a point mutation in DFF40/CAD abolish nuclease activity? | DFF40/CAD point-mutation knock-in. |
| Can overexpression of CD45 protect B cells from apoptosis? | CD45 overexpression in immature B cells. |
| Does BRCA1 knockdown affect DNA fragmentation? | BRCA1 knockout in breast cancer cells. |
| Can microRNA decoys modulate apoptotic gene expression? | MicroRNA overexpression or knockout. |
| Does NAC prevent methoxychlor-induced DNA fragmentation? | Granulosa cell culture with NAC treatment. |
How to Study the negative regulation of apoptotic DNA fragmentation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TUNEL | DNA fragmentation | Quantify apoptosis in cells and tissues. |
| Comet assay | DNA strand breaks | Single-cell DNA damage assessment. |
| Caspase-3 activity | Caspase-3 enzymatic activity | Monitor apoptotic pathway activation. |
| Western blot | Protein cleavage and expression | Detect DFF45/ICAD cleavage and DFF40/CAD release [2,4]. |
| qRT-PCR | mRNA expression | Measure transcriptional changes in apoptotic genes. |
| RNA-seq | Global gene expression | Identify pathways regulating DNA fragmentation. |
| CRISPR knockout | Gene function loss | Determine causal role of candidate genes. |
| Overexpression | Gain of function | Test protective effect of negative regulators. |
TUNEL assay
The TUNEL assay detects DNA fragmentation by labeling free 3'-OH ends with fluorescent nucleotides. It is widely used to quantify apoptotic DNA fragmentation and assess the effects of negative regulators.
Comet assay
The comet assay (single-cell gel electrophoresis) measures DNA strand breaks at the single-cell level. It can be used to evaluate whether negative regulators reduce apoptotic DNA fragmentation.
Caspase-3 activity assay
Caspase-3 activity is measured using colorimetric or fluorometric substrates. Since caspase-3 cleaves DFF45/ICAD, this assay indirectly assesses the activation of apoptotic DNA fragmentation.
Western blot for DFF45/ICAD and DFF40/CAD
Western blotting detects cleavage of DFF45/ICAD and release of DFF40/CAD, providing direct evidence of negative regulation at the protein level [2,4].
How CRISPR Can Be Used to Study GO:1902511 negative regulation of apoptotic DNA fragmentation
Knockout
CRISPR knockout of DFF45/ICAD or DFF40/CAD can be used to determine their essential roles in apoptotic DNA fragmentation. Knockout of negative regulators such as CD45 may increase DNA fragmentation [2,6].
Point Mutation
Point mutations in the nuclease domain of DFF40/CAD or in the inhibitory domain of DFF45/ICAD can dissect the structural basis of negative regulation [2,4].
Knock-in
Knock-in of tagged DFF45/ICAD or DFF40/CAD allows live-cell imaging and proteomic analysis of the inhibitory complex.
Overexpression
Overexpression of DFF45/ICAD or CD45 can protect cells from apoptotic DNA fragmentation, providing gain-of-function evidence for negative regulation [2,6].
How EDITGENE Supports negative regulation of apoptotic DNA fragmentation Research
Researchers studying negative regulation of apoptotic DNA fragmentation-related genes often need to determine whether a candidate gene is causally involved in preventing DNA cleavage or is merely correlated with survival. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of apoptotic DNA fragmentation research.
Frequently Asked Questions About negative regulation of apoptotic DNA fragmentation
What is negative regulation of apoptotic DNA fragmentation?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of apoptotic DNA fragmentation, as defined by GO:1902511.
What genes are involved in negative regulation of apoptotic DNA fragmentation?
Key genes include DFF45/ICAD, DFF40/CAD, CD45, BRCA1, BRCA2, and various microRNAs [2,4,5,6,8].
How is apoptotic DNA fragmentation inhibited?
It is inhibited by maintaining DFF40/CAD in an inactive complex with DFF45/ICAD, blocking caspase activation, or upregulating survival signals [2,4].
What is the role of DFF45/ICAD in apoptotic DNA fragmentation?
DFF45/ICAD binds to and inhibits DFF40/CAD, preventing DNA cleavage until caspases cleave DFF45/ICAD during apoptosis [2,4].
Which diseases are linked to defective negative regulation of apoptotic DNA fragmentation?
Cancer, autoimmune diseases, neurodegenerative disorders, and reproductive toxicity [2,3,6,7].
How can I study negative regulation of apoptotic DNA fragmentation in the lab?
Use TUNEL, comet assay, caspase-3 activity, Western blot, and CRISPR knockout/overexpression models [2,3,5].
What is the GO ID for negative regulation of apoptotic DNA fragmentation?
GO:1902511.
Can CRISPR be used to study negative regulation of apoptotic DNA fragmentation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools to dissect gene function [2,5,6].
What are the synonyms for negative regulation of apoptotic DNA fragmentation?
Synonyms include inhibition of apoptotic DNA fragmentation, downregulation of DNA catabolic process during apoptosis, and negative regulation of endonucleolytic DNA catabolic process involved in apoptosis.
Why is negative regulation of apoptotic DNA fragmentation important in cancer?
It allows cancer cells to evade apoptosis and resist chemotherapy, making it a therapeutic target [2,7].
Conclusion
GO:1902511 negative regulation of apoptotic DNA fragmentation is a critical biological process that safeguards genomic integrity by preventing inappropriate DNA cleavage during apoptosis. The interplay between DFF40/CAD and DFF45/ICAD, along with upstream signaling pathways, determines cell fate and influences diseases such as cancer and autoimmunity [2,4,6]. Leveraging CRISPR-based models and quantitative assays will continue to unravel the molecular mechanisms and therapeutic potential of this process [3,5,8].
References
- 1. Baechler BL et al.. 2019. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.. Autophagy 15(9):1606-1619 PMID: 30859901
- 2. Widlak P et al.. 2009. Roles of the major apoptotic nuclease-DNA fragmentation factor-in biology and disease.. Cell Mol Life Sci 66(2):263-74 PMID: 18810317
- 3. Bhardwaj JK et al.. 2020. N-acetyl-l-cysteine mediated regulation of DNA fragmentation, an apoptotic event, against methoxychlor toxicity in the granulosa cells of ovarian antral follicles.. Mutat Res Genet Toxicol Environ Mutagen 858-860:503222 PMID: 33198925
- 4. Fukushima K et al.. 2002. Solution structure of the DFF-C domain of DFF45/ICAD. A structural basis for the regulation of apoptotic DNA fragmentation.. J Mol Biol 321(2):317-27 PMID: 12144788
- 5. Andres JL et al.. 1998. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.. Oncogene 16(17):2229-41 PMID: 9619832
- 6. Ogimoto M et al.. 1994. Negative regulation of apoptotic death in immature B cells by CD45.. Int Immunol 6(4):647-54 PMID: 8018601
- 7. Guchelaar HJ et al.. 1997. Apoptosis: molecular mechanisms and implications for cancer chemotherapy.. Pharm World Sci 19(3):119-25 PMID: 9259027
- 8. Cui C et al.. 2014. Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors.. Cell Physiol Biochem 33(6):1698-714 PMID: 24923223
